Skip to content
White_Call

05/11/2024 – We are currently experiencing issues with our phonelines. We apologise for any inconvenience.  Until further notice, please contact us using the patient contact form https://www.sciensus.com/patient-enquiry/  

 

World Orphan Drug Congress

Meet us at the World Orphan Drug Congress 2024

Boston Convention and Exhibition Center

23-25 April

We’re delighted to confirm our attendance at the World Orphan Drug Congress 2024 in Boston, USA.

Join us and discover an end-to-end commercialisation partner for your rare and orphan medicines abroad.

Meet our experts

Andrew Cummins

Andrew Cummins

Director of Expanded Access Programs

Andrew Cummins is our Director of Expanded Access Programs. Speak to him about the best regulatory pathways that enable you to widen potentially lifesaving access to investigational and pre-approval medication.

LinkedIn icon

Gilbert Frishert

Gilbert Frishert

Director of Logistics

Gilbert Frishert is our Director of Logistics. Speak to him about overcoming the complex challenges of setting up and running an effective supply chain for rare and orphan drugs.

LinkedIn icon

Mathieu Loiseau

Mathieu Loiseau

Head of Rare Diseases Clinical Operations

Mathieu Loiseau is the Head of Rare Diseases Clinical Operations at Sciensus. Speak to him about how we can support your rare and orphan drugs in market, improving patient adherence and health outcomes.

LinkedIn icon